These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 33608003

  • 1. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.
    Hui C, Bai H, Liu J, Lu X, Wang S, Zhang Z, Jin M, Wang Y, Liu Y.
    Diagn Pathol; 2021 Feb 19; 16(1):13. PubMed ID: 33608003
    [Abstract] [Full Text] [Related]

  • 2. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M, the New Technology for Cervical Cancer 2 Working Group.
    J Natl Cancer Inst; 2021 Mar 01; 113(3):292-300. PubMed ID: 32745170
    [Abstract] [Full Text] [Related]

  • 3. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
    Guan Y, Peng J, Yuan C, Mi X, Chen Z, Chen J, Chen A, Liu J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan 01; 36(1):63-68. PubMed ID: 32314725
    [Abstract] [Full Text] [Related]

  • 4. HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade.
    Evans MF, Peng Z, Clark KM, Adamson CS, Ma XJ, Wu X, Wang H, Luo Y, Cooper K.
    PLoS One; 2014 Jan 01; 9(3):e91142. PubMed ID: 24625757
    [Abstract] [Full Text] [Related]

  • 5. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH.
    Am J Surg Pathol; 2017 May 01; 41(5):607-615. PubMed ID: 28403015
    [Abstract] [Full Text] [Related]

  • 6. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L, Husaiyin S, Zhao F, Rezhake R, Niyazi M.
    Clin Lab; 2018 Sep 01; 64(9):1363-1371. PubMed ID: 30274003
    [Abstract] [Full Text] [Related]

  • 7. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S.
    Oncol Rep; 2012 Jul 01; 28(1):346-52. PubMed ID: 22484610
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X, Wang S, Wu X, Qiu X, Li F, Zeng Y, Chen Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct 01; 34(10):937-941. PubMed ID: 30554588
    [Abstract] [Full Text] [Related]

  • 10. CIN grades possessing different HPV RNA location patterns and RNAscope is helpful tool for distinguishing squamous intraepithelial lesions in difficult cervical cases.
    Chen R, Zhang R, Zhang M, Liu S, Xie M, Yang Z, Shi Q, Chen H, Xiong H, Wang N, Jiang Q.
    Diagn Pathol; 2023 Feb 16; 18(1):23. PubMed ID: 36797728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z.
    BMC Cancer; 2019 Mar 27; 19(1):271. PubMed ID: 30917784
    [Abstract] [Full Text] [Related]

  • 13. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C, Zhu Y, Yang L, Zhang X, Liu L, Ren C.
    Arch Gynecol Obstet; 2018 Feb 25; 297(2):425-432. PubMed ID: 29143102
    [Abstract] [Full Text] [Related]

  • 15. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D, Weiss G, Lack B, Chen V, Fusco J.
    Arch Pathol Lab Med; 2012 Aug 25; 136(8):956-60. PubMed ID: 22849745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.
    Mol Diagn; 2004 Aug 25; 8(1):57-64. PubMed ID: 15230643
    [Abstract] [Full Text] [Related]

  • 18. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
    Coquillard G, Palao B, Patterson BK.
    Gynecol Oncol; 2011 Jan 25; 120(1):89-93. PubMed ID: 20950847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.